Skip to content

Bruker BRKR Other Noncash Income (Expense)

Other Noncash Income (Expense) at other companies

Thermo Fisher Scientific logo
Thermo Fisher ScientificTMO
Agilent Technologies logo
Agilent TechnologiesA
Illumina logo
IlluminaILMN
Charles River Laboratories logo
Charles River LaboratoriesCRL
Onto Innovation logo
Onto InnovationONTO

Other financials

Income statement

See full
Revenue$823.4M+2.7%
Gross profit$379.8M-2.9%
Operating income$10.2M-67.9%
Net income$14.4M-17.2%
EPS (diluted)$0.02-81.8%

Balance sheet

See full
Cash & equivalents$137.6M-26.7%
Total debt$1.7B-20.9%
Total equity$2.5B+34.6%
Total assets$6.1B+3.3%

Cash flow

See full
Operating cash flow$71.2M+9.5%
CapEx$24.2M-6.9%
Free cash flow$47.0M+20.5%

Valuation

See full
Market cap$8.71B-13.2%
Enterprise value$10.25B-14.9%
P/S2.5×-0.4×

Profitability

See full
Gross margin45.3%-3.7pp
Operating margin1.3%-5.0pp
Net margin-0.6%-10.0pp
FCF margin1.5%-3.6pp

Returns & leverage

See full
Return on equity-1%-21.2pp
Debt / equity0.7×-0.5×
Current ratio1.6×0.0×

Where this comes from

Reported directly by Bruker in its filing.

Tagged under the XBRL concept us-gaap:OtherNoncashIncomeExpense.

The official record: Bruker’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Bruker's other noncash income (expense).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Bruker's other noncash income (expense)?
Bruker (BRKR) reported other noncash income (expense) of -$21.4M in Q1 2026.
How has Bruker's other noncash income (expense) changed year-over-year?
Bruker's other noncash income (expense) decreased by 286.1% year-over-year, from $11.5M to -$21.4M.
What is the long-term trend for Bruker's other noncash income (expense)?
Over 3 years (2021 to 2025), Bruker's other noncash income (expense) has grown at a -0.1% compound annual growth rate (CAGR), from -$28M to -$27.9M.